Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001628280-25-059113
Filing Date
2025-12-30
Accepted
2025-12-30 16:28:09
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 2907
  Complete submission text file 0001628280-25-059113.txt   4376
Mailing Address VICURON PHARMACEUTICALS INC 455 S GULPH ROAD SUITE 305 KING OF PRUSSIA PA 19406
Business Address
DUNTON ALAN W (Reporting) CIK: 0001304773 (see all company filings)

Type: 144

Mailing Address 300 CONNELL DRIVE SUITE 4200 BERKELEY HEIGHTS NJ 07922
Business Address 300 CONNELL DRIVE SUITE 4200 BERKELEY HEIGHTS NJ 07922 908-517-9500
CorMedix Inc. (Subject) CIK: 0001410098 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-34673 | Film No.: 251614631
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)